Trial · NCT00535938
Results by group88
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 88
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cervical Dystonia | Naïve to Botox® Treatment | Baseline | 0.650 | Standard Deviation 0.154 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cervical Dystonia | Non-naïve to Botox® Treatment | Baseline | 0.676 | Standard Deviation 0.143 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cervical Dystonia | Naïve to Botox® Treatment | Change from Baseline at SV1 (N=33,174) | 0.020 | Standard Deviation 0.084 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cervical Dystonia | Non-naïve to Botox® Treatment | Change from Baseline at SV1 (N=33,174) | -0.001 | Standard Deviation 0.104 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Blepharospasm | Naïve to Botox® Treatment | Baseline | 0.718 | Standard Deviation 0.122 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Blepharospasm | Non-naïve to Botox® Treatment | Baseline | 0.754 | Standard Deviation 0.132 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Blepharospasm | Naïve to Botox® Treatment | Change from Baseline at SV1 (N=21, 51) | 0.053 | Standard Deviation 0.156 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Blepharospasm | Non-naïve to Botox® Treatment | Change from Baseline at SV1 (N=21, 51) | 0.014 | Standard Deviation 0.120 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Hyperhidrosis | Naïve to Botox® Treatment | Baseline | 0.782 | Standard Deviation 0.129 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Hyperhidrosis | Non-naïve to Botox® Treatment | Baseline | 0.799 | Standard Deviation 0.115 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Hyperhidrosis | Naïve to Botox® Treatment | Change from Baseline at SV1 (N=58, 60) | 0.010 | Standard Deviation 0.136 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Hyperhidrosis | Non-naïve to Botox® Treatment | Change from Baseline at SV1 (N=58, 60) | -0.000 | Standard Deviation 0.124 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cerebral Palsy | Naïve to Botox® Treatment | Baseline | 0.712 | Standard Deviation 0.131 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cerebral Palsy | Non-naïve to Botox® Treatment | Baseline | 0.733 | Standard Deviation 0.117 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cerebral Palsy | Naïve to Botox® Treatment | Change from Baseline at SV1 (N=0, 8) | NA | Standard Deviation NA | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Cerebral Palsy | Non-naïve to Botox® Treatment | Change from Baseline at SV1 (N=0, 8) | 0.018 | Standard Deviation 0.114 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Adult Focal Spasticity | Naïve to Botox® Treatment | Baseline | 0.621 | Standard Deviation 0.111 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Adult Focal Spasticity | Non-naïve to Botox® Treatment | Baseline | 0.635 | Standard Deviation 0.124 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Adult Focal Spasticity | Naïve to Botox® Treatment | Change from Baseline at Week 4 (N=114, 201) | 0.002 | Standard Deviation 0.096 | Scores on a Scale |
| Change From Baseline in the SF-6D Measure Health Utility (Quality of Life) Score Using the SF-12® Questionnaire for Patients With Adult Focal Spasticity | Non-naïve to Botox® Treatment | Change from Baseline at Week 4 (N=114, 201) | 0.008 | Standard Deviation 0.096 | Scores on a Scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00535938/results